MyFinsight
Home
Blog
About
Contact
Net decrease in cash
and cash...
-$30,325K
Accretion expense of
deferred royalty...
$6,839K
Share-based compensation
expense
$2,442K
Other long-term
liabilities
$2,204K
Prepaid expenses and
other current assets
-$2,007K
Write-downs of inventory
$1,473K
Amortization of debt
discount, senior secured...
$225K
Amortization of operating
lease right-of-use...
$114K
Inventory
-$16K
Proceeds from the
exercise of stock options
$205K
Net cash used in
operating activities
-$29,710K
Net cash (used in)/
provided by financing...
-$583K
Net cash used in
investing activities
-$32K
Canceled cashflow
$15,320K
Canceled cashflow
$205K
Net loss
-$32,968K
Taxes paid related to
net settled equity...
$768K
Payment for purchases of
property and equipment
$32K
Accounts payable
-$3,874K
Accrued expenses and
other current...
-$3,183K
Warrant obligations,
decrease in fair value
-$2,227K
Accounts receivable, net
$1,928K
Other
$603K
Operating lease
liabilities
-$247K
Proceeds from the sale of
common shares, net of...
-$20K
Back
Back
Cash Flow
ADC Therapeutics SA (ADCT)
ADC Therapeutics SA (ADCT)
source: myfinsight.com